Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06361836 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06361836 · ClinicalTrials.gov record · last posted 2026-02-20

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa

Name: Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa — clinical trial record (NCT06361836)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Regulate-HS

StatusActive, Not Recruiting

PhasePhase 1

SponsorSonoma Biotherapeutics, Inc.

Started2024-10-09

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study will test the safety and effects of SBT777101 when given as a single dose to subjects with hidradenitis suppurativa. Increasing dose levels will be given after the safety at lower dose levels is shown.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2024-04-08; most recent amendment 2026-02-18. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2026-02-18

Status change Recruiting→Active, Not Recruitingv5

Trial Details

NCT Number	NCT06361836
Lead Sponsor	Sonoma Biotherapeutics, Inc.
Conditions	Hidradenitis Suppurativa
Enrollment	24 participants
Start Date	2024-10-09
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-02-20